Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.26), $0.10 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.